Press & Media

Press Releases

Accelerating Medicines Partnership Announces Awards to Advance Research in Type 2 Diabetes

PDF release >>
The Foundation for the National Institutes of Health (FNIH) will award more than $3 and a half million to further the study of Type 2 Diabetes (T2D) as part of an unprecedented collaboration to develop new ways to diagnose and treat several pressing diseases.

Foundation for the NIH to Award Lurie Prize in Biomedical Sciences to Karl Deisseroth for Innovative Advances in Brain Research and Technology

Medal Recognizes the Development of Optogenetics and CLARITY, New Tools to Understand the Brain
PDF release >>

The Foundation for the National Institutes of Health (FNIH) has selected Karl Deisseroth, M.D., Ph.D., as the 2015 winner of the Lurie Prize in Biomedical Sciences for the development of optogenetics and CLARITY as tools to study the functions of cells, especially neurons. Dr. Deisseroth is being recognized for leading the development of optogenetics, a technology for controlling cells with light to determine function, as well as for CLARITY, a method for transforming intact organs into transparent polymer gels to allow visualization of biological structures with high resolution and detail. The Lurie Prize will be presented to Dr. Deisseroth on May 20, 2015 in Washington, D.C.

2015 FNIH Award Ceremony — May 20, 2015

On Wednesday, May 20, the Foundation for the National Institutes of Health (FNIH) will bring together leaders from biomedical science, the biotech and pharmaceutical industries, philanthropy and business, for the 2015 FNIH Award Ceremony and presentation of the Lurie Prize in Biomedical Sciences.

John & Marcia Goldman Foundation Donates to NIH Ebola Research

PDF release >>
Bethesda, MD.
, November 5, 2014 – In the first donation of its kind for the Foundation for the National Institutes of Health (FNIH), the John & Marcia Goldman Foundation has awarded $25,000 to support Ebola research in West Africa conducted by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health.

Lung-MAP Collaborative Clinical Trial Rapidly Expanding Across the Country

PDF release >>
The Lung-MAP trial, a multi-drug, multi-sub-study, biomarker-driven clinical trial for patients with advanced squamous cell lung cancer, that launched on June 16th 2014, today announced that it has expanded to an additional 169 locations throughout the United States. They join 85 locations that have been participating in the trial since the June launch. All locations can be found here: http://www.lung-map.org/locations

Groundbreaking Collaborative Clinical Trial Launched

PDF release >>
A unique public-private collaboration among the National Cancer Institute (NCI), part of the National Institutes of Health, SWOG Cancer Research, Friends of Cancer Research (Friends), the Foundation for the National Institutes of Health (FNIH), five pharmaceutical companies (Amgen, Genentech, Pfizer, AstraZeneca, and AstraZeneca’s global biologics R&D arm, MedImmune), and Foundation Medicine today announced the initiation of the Lung Cancer Master Protocol (Lung-MAP) trial.

Research Partnership Defines Diagnostic Criteria for Sarcopenia, a Debilitating Condition in Older Adults

PDF release >>
Bethesda, Md., April 15, 2014 — Low muscle mass and weakness are important contributors to sarcopenia, a common and potentially disabling condition in older adults. Diagnostic criteria have been proposed, but no consensus yet exists.

Foundation for the NIH to Award Lurie Prize in the Biomedical Sciences to Jennifer Doudna from UC Berkeley

The Foundation for the National Institutes of Health (FNIH) has selected Jennifer Doudna, Ph.D., a Professor from the University of California, Berkeley, as the second winner of its Lurie Prize in the Biomedical Sciences. Doudna, a Howard Hughes Investigator and Professor of Biochemistry, Biophysics and Structural Biology, will be presented the Lurie Prize medal and a $100,000 honorarium on May 20 in Washington, D.C.

AADR Provides Support to the Foundation for the NIH for a Dental Student in the NIH Medical Research Scholars Program

PDF release >>
Alexandria, Va., USA
- The American Association for Dental Research (AADR), with the Foundation for the National Institutes of Health (FNIH), today announced that AADR will provide $75,000 funding to support one dental student competitively selected to participate in the 2014-2015 NIH Medical Research Scholars Program (MRSP).

Foundation for the NIH Announces First Results of I-SPY 2 Breast Cancer Clinical Trial

PDF release >>
The I-SPY 2 TRIAL, a randomized phase II clinical trial for breast cancer launched through a unique partnership with the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium and sponsored by QuantumLeap Healthcare Collaborative has graduated the first two drugs from its innovative, multidrug standing platform trial.